Literature DB >> 17618488

Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles.

Hui-Li Ma1, Xian-Rong Qi, Wu-Xiao Ding, Yoshie Maitani, Tsuneji Nagai.   

Abstract

Ferrofluids are attractive candidates for magnetic targeting system because of their fluidity and magnetism. The magnetic nanoparticles in ferrofluids should have combined properties of superparamagnetic behavior, target localization, and biocompatibility. The magnetic targeting and biocompatibility of superparamagnetic iron oxide nanoparticles stabilized by alginate (SPION-alginate) was investigated in vitro and in vivo. The localization of SPION-alginate by an external magnetic field in vitro was quantitatively evaluated by determining the iron content, and the results revealed that the localization ratio of SPION-alginate was 56%. Magnetic targeting of the SPION-alginate after femoral artery administration with the magnetic field in rats was quantitatively investigated by iron content and qualitatively confirmed by histological evaluation and magnetic resonance imaging. The ratio of iron content between the target site and the nontarget site were 8.88 at 0.5 h and 7.50 at 2 h, respectively. The viability of RAW264.7 cells and L929 cells was apparently unaltered upon exposure to SPION-alginate. The incubation with erythrocytes indicated that the SPION-alginate did not induce erythrocytes hemolysis and aggregation. In conclusions, the SPION-alginate had magnetic targeting with an external magnetic field and did not be detained at the injection site without the magnetic field. The SPION-alginate was generally considered to be biocompatible in cytotoxicity and hemolysis aspects. (c) 2007 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17618488     DOI: 10.1002/jbm.a.31346

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  6 in total

1.  Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles.

Authors:  Michael Chorny; Elizabeth Hood; Robert J Levy; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2010-05-18       Impact factor: 9.776

2.  Multifunctional particles for melanoma-targeted drug delivery.

Authors:  Aniket S Wadajkar; Zarna Bhavsar; Cheng-Yu Ko; Bhanuprasanth Koppolu; Weina Cui; Liping Tang; Kytai T Nguyen
Journal:  Acta Biomater       Date:  2012-05-03       Impact factor: 8.947

3.  A novel human artery model to assess the magnetic accumulation of SPIONs under flow conditions.

Authors:  Agata Janikowska; Jasmin Matuszak; Stefan Lyer; Eveline Schreiber; Harald Unterweger; Jan Zaloga; Jürgen Groll; Christoph Alexiou; Iwona Cicha
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

Review 4.  Nanotechnology for the treatment of melanoma skin cancer.

Authors:  Lucas B Naves; Chetna Dhand; Jayarama Reddy Venugopal; Lakshminarayanan Rajamani; Seeram Ramakrishna; Luis Almeida
Journal:  Prog Biomater       Date:  2017-03-16

5.  Drug delivery to atherosclerotic plaques using superparamagnetic iron oxide nanoparticles.

Authors:  Jasmin Matuszak; Barbara Lutz; Aleksander Sekita; Jan Zaloga; Christoph Alexiou; Stefan Lyer; Iwona Cicha
Journal:  Int J Nanomedicine       Date:  2018-12-11

Review 6.  Magnetic nanoparticles for theragnostics.

Authors:  Veronica I Shubayev; Thomas R Pisanic; Sungho Jin
Journal:  Adv Drug Deliv Rev       Date:  2009-04-20       Impact factor: 15.470

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.